- Home
- SYPR vs AKTX Comparison
SYPR vs AKTX Comparison
Compare SYPR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- AKTX
- Stock Information
- Founded
- SYPR 1997
- AKTX N/A
- Country
- SYPR United States
- AKTX United States
- Employees
- SYPR N/A
- AKTX N/A
- Industry
- SYPR Industrial Machinery/Components
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- AKTX Health Care
- Exchange
- SYPR Nasdaq
- AKTX Nasdaq
- Market Cap
- SYPR 31.2M
- AKTX 29.5M
- IPO Year
- SYPR 1994
- AKTX N/A
- Fundamental
- Price
- SYPR $1.38
- AKTX $1.30
- Analyst Decision
- SYPR
- AKTX
- Analyst Count
- SYPR 0
- AKTX 0
- Target Price
- SYPR N/A
- AKTX N/A
- AVG Volume (30 Days)
- SYPR 15.8K
- AKTX 49.2K
- Earning Date
- SYPR 11-12-2024
- AKTX 11-19-2024
- Dividend Yield
- SYPR N/A
- AKTX N/A
- EPS Growth
- SYPR N/A
- AKTX N/A
- EPS
- SYPR N/A
- AKTX N/A
- Revenue
- SYPR $141,466,000.00
- AKTX N/A
- Revenue This Year
- SYPR N/A
- AKTX N/A
- Revenue Next Year
- SYPR N/A
- AKTX N/A
- P/E Ratio
- SYPR N/A
- AKTX N/A
- Revenue Growth
- SYPR 7.82
- AKTX N/A
- 52 Week Low
- SYPR $1.27
- AKTX $1.08
- 52 Week High
- SYPR $2.30
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- SYPR 43.06
- AKTX 26.66
- Support Level
- SYPR $1.34
- AKTX $1.77
- Resistance Level
- SYPR $1.47
- AKTX $2.45
- Average True Range (ATR)
- SYPR 0.08
- AKTX 0.27
- MACD
- SYPR 0.01
- AKTX -0.10
- Stochastic Oscillator
- SYPR 43.75
- AKTX 13.67
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sale of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).